CreditReports.dk
HomeScreen companies

Optoceutics ApS Financials, key figures and credit report

CVR number: 39769689 Established 2018 Industry: 72 Scientific research and development
Company contact details
Nørrebrogade 45 C, 2200 København N msc@optoceutics.com tel: 23456442 www.optoceutics.com
Gross profit -2 585.6 kDKK FY 2025 -397.9% vs 2024
EBIT -8 440.2 kDKK FY 2025 +9.3% vs 2024
Net debt 5 415.8 kDKK FY 2025 +162.4% vs 2024
Quick ratio 1.3 FY 2025 -9.1 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit34.684 262.72909.64- 519.34-2 585.56
Employee benefit expenses-5 452.39-7 568.54-8 424.68-8 046.64-5 114.52
Total depreciation- 750.00- 535.66- 740.13- 740.13
EBIT-5 417.71-4 055.81-8 050.70-9 306.11-8 440.22
Other financial income0.0711.8118.26182.05258.04
Other financial expenses-68.56-1 007.93- 601.03- 944.18-1 023.16
Pre-tax profit-5 486.20-5 051.94-8 633.47-10 068.24-9 205.33
Income taxes1 605.821 416.271 421.95883.61469.17
Net earnings-3 880.38-3 635.66-7 211.52-9 184.63-8 736.15

Assets (kDKK)

2021
2022
2023
2024
2025
Development expenditure12 244.7615 934.5118 326.1721 694.2425 336.06
Intangible rights629.38825.761 800.621 708.831 617.04
Intangible assets total12 874.1416 760.2820 126.7923 403.0726 953.11
Tangible assets total
Holdings in group member companies70.4470.442 024.65
Investments total114.15481.67416.02201.962 164.76
Long term receivables total
Raw materials and consumables1 041.431 148.02497.931 706.92
Finished products/goods161.51691.93734.3435.74
Inventories total161.511 733.361 882.36533.681 706.92
Current trade debtors818.623.14
Current amounts owed by group member comp.13.83292.653 665.626 069.48
Prepayments and accrued income1.3861.82129.78
Current other receivables33.5753.8512 149.508 359.63615.63
Current deferred tax assets1 334.941 019.95809.02883.61943.84
Short term receivables total1 382.341 073.8014 071.1712 970.697 761.86
Cash and bank deposits11 913.999 876.824 319.278 913.824 990.88
Cash and cash equivalents11 913.999 876.824 319.278 913.824 990.88
Balance sheet total (assets)26 446.1329 925.9240 815.6146 023.2243 577.52

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital82.9089.0397.01103.30108.99
Other reserves9 550.9112 428.9226 099.1124 097.2419 762.13
Retained earnings7 613.878 060.829 929.6119 048.1421 185.19
Profit of the financial year-3 880.38-3 635.66-7 211.52-9 184.63-8 736.15
Shareholders equity total13 367.3116 943.1128 914.2134 064.0632 320.16
Provisions9 509.2510 084.65
Capital loans8 500.009 471.7210 058.699 860.701 606.65
Non-current liabilities total8 500.009 471.7210 058.699 860.701 606.65
Current loans from credit institutions1 116.758 800.00
Advances received1 289.37
Current trade creditors87.37222.15856.38269.97
Short-term deferred tax liabilities474.67
Other non-interest bearing current liabilities364.45144.74553.34125.32106.08
Accruals and deferred income3 117.752 531.27
Current liabilities total3 569.562 898.161 842.722 098.469 650.71
Balance sheet total (liabilities)34 946.1339 397.6440 815.6146 023.2243 577.52
Page generated